APTITUDE Trial Management Group (2018). A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitisAthimalaipet V. Ramanan,Andrew D. Dick,Ashley P. Jones,Catherine Guly,Ben Hardwick,Helen Hickey,Richard Lee,Andrew McKay,Michael W. Beresfordsemanticscholar（2018）引用 0|浏览0AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
